CS900287A2 - Method of phosphinic acid's derivatives production - Google Patents

Method of phosphinic acid's derivatives production

Info

Publication number
CS900287A2
CS900287A2 CS879002A CS900287A CS900287A2 CS 900287 A2 CS900287 A2 CS 900287A2 CS 879002 A CS879002 A CS 879002A CS 900287 A CS900287 A CS 900287A CS 900287 A2 CS900287 A2 CS 900287A2
Authority
CS
Czechoslovakia
Prior art keywords
phosphinic acid
derivatives production
derivatives
production
phosphinic
Prior art date
Application number
CS879002A
Other languages
English (en)
Other versions
CS272231B2 (en
Inventor
Michael J Broadhurst
Balraj K Handa
William H Johnson
Geoffrey Lawton
Peter J Machin
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868629876A external-priority patent/GB8629876D0/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CS900287A2 publication Critical patent/CS900287A2/cs
Publication of CS272231B2 publication Critical patent/CS272231B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CS879002A 1986-12-15 1987-12-09 Method of phosphinic acid's derivatives production CS272231B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868629876A GB8629876D0 (en) 1986-12-15 1986-12-15 Phosphinic acid derivatives
GB878722245A GB8722245D0 (en) 1986-12-15 1987-09-22 Phosphinic acid derivatives

Publications (2)

Publication Number Publication Date
CS900287A2 true CS900287A2 (en) 1990-03-14
CS272231B2 CS272231B2 (en) 1991-01-15

Family

ID=26291694

Family Applications (1)

Application Number Title Priority Date Filing Date
CS879002A CS272231B2 (en) 1986-12-15 1987-12-09 Method of phosphinic acid's derivatives production

Country Status (19)

Country Link
US (2) US4885283A (cs)
EP (1) EP0276436B1 (cs)
CN (1) CN1017337B (cs)
AU (1) AU606901B2 (cs)
CA (1) CA1326737C (cs)
CS (1) CS272231B2 (cs)
DE (1) DE3786250T2 (cs)
DK (1) DK641687A (cs)
ES (1) ES2056810T3 (cs)
FI (1) FI89059C (cs)
HU (1) HU203109B (cs)
IE (1) IE62334B1 (cs)
IL (1) IL84766A (cs)
MC (1) MC1881A1 (cs)
NO (1) NO171788C (cs)
NZ (1) NZ222824A (cs)
PH (1) PH25030A (cs)
PT (1) PT86366B (cs)
ZW (1) ZW23187A1 (cs)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0347840B1 (en) * 1988-06-23 1995-12-27 Banyu Pharmaceutical Co., Ltd. Phosphinic acid derivates
US5183900A (en) * 1990-11-21 1993-02-02 Galardy Richard E Matrix metalloprotease inhibitors
US5189178A (en) * 1990-11-21 1993-02-23 Galardy Richard E Matrix metalloprotease inhibitors
US5268384A (en) * 1990-11-21 1993-12-07 Galardy Richard E Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors
US5239078A (en) 1990-11-21 1993-08-24 Glycomed Incorporated Matrix metalloprotease inhibitors
US5114953A (en) * 1990-11-21 1992-05-19 University Of Florida Treatment for tissue ulceration
CA2058797A1 (en) * 1991-02-01 1992-08-02 Michael John Broadhurst Amino acid derivatives
FR2676059B1 (fr) * 1991-05-02 1993-07-23 Commissariat Energie Atomique Nouveaux derives de peptides utilisables comme inhibiteurs de collagenases bacteriennes.
EP0520573A1 (en) * 1991-06-27 1992-12-30 Glaxo Inc. Cyclic imide derivatives
EP0623143A1 (en) * 1992-01-15 1994-11-09 Merck & Co. Inc. Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents
US5326760A (en) * 1992-06-29 1994-07-05 Glaxo, Inc. Aminobutanoic acid compounds having metalloprotease inhibiting properties
US6037472A (en) * 1993-11-04 2000-03-14 Syntex (U.S.A.) Inc. Matrix metalloprotease inhibitors
WO1995014033A1 (en) * 1993-11-19 1995-05-26 Aktiebolaget Astra Novel dipeptide derivatives
GB9405076D0 (en) 1994-03-16 1994-04-27 Inst Of Ophtalmology A medical use of matrix metalloproteinase inhibitors
US5476847A (en) * 1994-06-29 1995-12-19 Schering Corporation Derivatives of phosphinic acid useful as endothelin converting enzyme inhibitors
US5840698A (en) * 1994-10-27 1998-11-24 Affymax Technologies N.V. Inhibitors of collagenase-1 and stormelysin-I metalloproteases, pharmaceutical compositions comprising same and methods of their use
US5831004A (en) 1994-10-27 1998-11-03 Affymax Technologies N.V. Inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use
US6011021A (en) * 1996-06-17 2000-01-04 Guilford Pharmaceuticals Inc. Methods of cancer treatment using naaladase inhibitors
FR2730235A1 (fr) * 1995-02-06 1996-08-09 Commissariat Energie Atomique Nouveaux derives de peptides utilisables comme inhibiteur de l'endopeptidase a zinc 24-15
US6500948B1 (en) 1995-12-08 2002-12-31 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof
IL138027A (en) * 1995-12-08 2004-08-31 Agouron Pharma Intermediates for the preparation and preparation of metalloproteinase inhibitors
DE69624081T2 (de) * 1995-12-20 2003-06-12 Agouron Pharmaceuticals, Inc. Matrix-metalloprotease Inhibitoren
US5795877A (en) * 1996-12-31 1998-08-18 Guilford Pharmaceuticals Inc. Inhibitors of NAALADase enzyme activity
US6025345A (en) * 1996-06-17 2000-02-15 Guilford Pharmaceuticals Inc. Inhibitors of NAALADase enzyme activity
US6071965A (en) * 1996-06-17 2000-06-06 Guilford Pharmaceuticals Inc. Phosphinic alkanoic acid derivatives
KR20000016750A (ko) 1996-06-17 2000-03-25 토마스 씨. 서 Naaladase 억제를 이용한 암의 치료방법.
US6046180A (en) * 1996-06-17 2000-04-04 Guilford Pharmaceuticals Inc. NAALADase inhibitors
US6054444A (en) * 1997-04-24 2000-04-25 Guilford Pharmaceuticals Inc. Phosphonic acid derivatives
US5902817A (en) * 1997-04-09 1999-05-11 Guilford Pharmaceuticals Inc. Certain sulfoxide and sulfone derivatives
US6384022B1 (en) 1996-06-17 2002-05-07 Guilford Pharmaceuticals Inc. Prodrugs of NAALAdase inhibitors
US5977090A (en) * 1996-09-27 1999-11-02 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating compulsive disorders using NAALADase inhibitors
US5672592A (en) * 1996-06-17 1997-09-30 Guilford Pharmaceuticals Inc. Certain phosphonomethyl-pentanedioic acid derivatives thereof
US6025344A (en) 1996-06-17 2000-02-15 Guilford Pharmaceuticals Inc. Certain dioic acid derivatives useful as NAALADase inhibitors
US5863536A (en) * 1996-12-31 1999-01-26 Guilford Pharmaceuticals Inc. Phosphoramidate derivatives
YU1899A (sh) * 1996-07-18 2000-03-21 Pfizer Inc. Inhibitori matričnih metaloproteaza na bazi fosfinata
US6953788B1 (en) 1996-09-19 2005-10-11 Aventis Pharmaceuticals Inc. 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
US5962521A (en) 1997-04-04 1999-10-05 Guilford Pharmaceuticals Inc. Hydroxamic acid derivatives
US6008243A (en) * 1996-10-24 1999-12-28 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use
US6174915B1 (en) 1997-03-25 2001-01-16 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
US5985900A (en) * 1997-04-01 1999-11-16 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
US5981209A (en) * 1997-12-04 1999-11-09 Guilford Pharmaceuticals Inc. Use of NAALADase activity to identify prostate cancer and benign prostatic hyperplasia
US6028216A (en) * 1997-12-31 2000-02-22 Guilford Pharmaceuticals Inc. Asymmetric syntheses and intermediates for preparing enantiomer-enriched hydroxyphosphinyl derivatives
US6121252A (en) * 1998-03-30 2000-09-19 Guilford Pharmaceuticals Inc. Phosphinic acid derivatives
US6329418B1 (en) 1998-04-14 2001-12-11 The Procter & Gamble Company Substituted pyrrolidine hydroxamate metalloprotease inhibitors
US6265609B1 (en) 1998-07-06 2001-07-24 Guilford Pharmaceuticals Inc. Thio-substituted pentanedioic acid derivatives
US6395718B1 (en) 1998-07-06 2002-05-28 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of inhibiting angiogenesis using naaladase inhibitors
JP4503836B2 (ja) 1998-07-06 2010-07-14 エイザイ インコーポレイテッド 医薬化合物及び組成物として有用なＮＡＡＬＡＤａｓｅ阻害剤
HRP990246A2 (en) 1998-08-07 2000-06-30 Du Pont Pharm Co Succinoylamino benzodiazepines as inhibitors of a beta protein production
NZ509241A (en) 1998-08-07 2003-08-29 Du Pont Pharm Co Succinoylamino lactams as inhibitors of alpha-beta protein production
CA2346099A1 (en) * 1998-11-12 2000-05-18 Dupont Pharmaceuticals Company Use of radioligands to screen inhibitors of amyloid-beta peptide production
US6737038B1 (en) 1998-11-12 2004-05-18 Bristol-Myers Squibb Company Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production and for diagnostic imaging
US6313159B1 (en) 1999-08-20 2001-11-06 Guilford Pharmaceuticals Inc. Metabotropic glutamate receptor ligand derivatives as naaladase inhibitors
GB9922577D0 (en) * 1999-09-23 1999-11-24 Center For Clinical & Basic Re Substituted phosphinate based peptide derivatives
US6696456B1 (en) 1999-10-14 2004-02-24 The Procter & Gamble Company Beta disubstituted metalloprotease inhibitors
CZ20023179A3 (cs) * 2000-03-21 2003-02-12 The Procter And Gamble Company Metalloproteázové inhibitory zahrnující vedlejší karbocyklický řetězec
EP1265865A2 (en) * 2000-03-21 2002-12-18 The Procter & Gamble Company Difluorobutyric acid derivatives and their use as metalloprotease inhibitors
HUP0300235A2 (hu) 2000-03-21 2003-08-28 The Procter & Gamble Co. Heterociklikus oldalláncot tartalmazó, N-szubsztituált metalloproteáz inhibitorok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
AU783857B2 (en) 2000-06-01 2005-12-15 Bristol-Myers Squibb Pharma Company Lactams substituted by cyclic succinates as inhibitors of a beta protein production
US8283135B2 (en) 2000-06-30 2012-10-09 The Procter & Gamble Company Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
AU2003233154A1 (en) 2002-06-10 2003-12-22 Pfizer Inc. Metabolites of prinomastat and their sythesis
PT3122757T (pt) 2014-02-28 2023-11-03 Hangzhou Dac Biotech Co Ltd Ligantes carregados e as suas utilizações em conjugação

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4226610A (en) * 1978-04-15 1980-10-07 Meiji Selka Kaisha, Ltd. Herbicidal compounds, preparation thereof and herbicides containing the same
JPS60163899A (ja) * 1984-02-03 1985-08-26 Sankyo Co Ltd レニン阻害ペプチド類
US4661473A (en) * 1984-03-27 1987-04-28 Merck & Co., Inc. Renin inhibitors containing peptide isosteres
EP0210545A3 (en) * 1985-07-24 1988-07-20 Merck & Co. Inc. Phosphorous containing enzyme inhibitors
EP0209848A3 (en) * 1985-07-24 1988-07-27 Merck & Co. Inc. Enzyme inhibitors

Also Published As

Publication number Publication date
HU203109B (en) 1991-05-28
FI89059C (fi) 1993-08-10
PH25030A (en) 1991-01-28
US5006651A (en) 1991-04-09
NO171788C (no) 1993-05-05
NZ222824A (en) 1990-08-28
NO171788B (no) 1993-01-25
IL84766A0 (en) 1988-05-31
US4885283A (en) 1989-12-05
NO875214L (no) 1988-06-16
ES2056810T3 (es) 1994-10-16
IE62334B1 (en) 1995-01-25
AU8217687A (en) 1988-06-16
IE873383L (en) 1988-06-15
NO875214D0 (no) 1987-12-14
EP0276436B1 (en) 1993-06-16
AU606901B2 (en) 1991-02-21
HUT46699A (en) 1988-11-28
CA1326737C (en) 1994-02-01
EP0276436A1 (en) 1988-08-03
MC1881A1 (fr) 1989-01-24
CS272231B2 (en) 1991-01-15
DK641687D0 (da) 1987-12-07
DE3786250D1 (en) 1993-07-22
DE3786250T2 (de) 1993-10-07
ZW23187A1 (en) 1988-06-29
FI875484A0 (fi) 1987-12-14
FI89059B (fi) 1993-04-30
CN87101164A (zh) 1988-06-29
PT86366B (pt) 1990-11-20
FI875484A7 (fi) 1988-06-16
IL84766A (en) 1994-02-27
CN1017337B (zh) 1992-07-08
PT86366A (en) 1988-01-01
DK641687A (da) 1988-06-16

Similar Documents

Publication Publication Date Title
CS900287A2 (en) Method of phosphinic acid's derivatives production
CS747588A2 (en) Method of 5-deoxy-5-fluorcytidine's new derivatives production
PL268098A1 (en) The method of manufacture of new derivatives of naphtiridin- or quinolincarboxy acid
SG64893G (en) Method for production of stable nicorandil preparation
CS8605412A2 (en) Method of poly-4-aminopyrrole-2-amides' derivatives production
PL264629A1 (en) A method of 1,2,3,4 tetrahydropirymidinecarboxyl acid derivatives production
ZA87279B (en) Method for production of stable nicorandil preparation
CS705788A2 (en) Method of purine's new derivatives production
CS412388A2 (en) Method of 7-piperazino-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxyl acid's derivatives production
CS232786A2 (en) Method of androstane-17 beta-carboxyl acid's new esters production
EP0285421A3 (en) Method of producing phosphatidic acid derivatives
CS554387A2 (en) Method of pyrimidine's new derivatives production
CS837885A2 (en) Method of silibinene's new derivatives production
CS523687A2 (en) Method of pyrimidine's new derivatives production
CS872287A2 (en) Method of new triazine's derivatives production
PL272668A1 (en) Method of obtaining 4,4'-dinitroethylbenedisulfonic-2,2'acid
CS8703287A1 (en) Method of 2-benzothiazolsulphenic acid's sulphenamides preparation
CS592687A2 (en) Method of l-diaminocarboxyl acid's ester production
CS910288A2 (en) Method of dioxazocine's derivatives production
CS810187A2 (en) Method of 2-guanidinothiazole's derivative production
EP0240362A3 (en) Process for the preparation of 4'-hydroxybiphenyl-4-carboxylic acid
CS391288A1 (en) Method of 3,4-dichloroaniline-6-sulphonic acid's production
CS746987A2 (en) Method of quinoline-carboxylic acid's derivatives production
CS755487A2 (en) Method of acrylic acid's derivatives production
CS286788A1 (en) Method of 2, 3 to 4, 6-diisopropylidene-2-keto-l-gulonic acid preparation